Madison Investment Advisors LLC acquired a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 178,236 shares of the company's stock, valued at approximately $4,135,000. Madison Investment Advisors LLC owned approximately 0.10% of Option Care Health at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Wellington Management Group LLP grew its stake in Option Care Health by 15.5% during the third quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company's stock worth $310,650,000 after buying an additional 1,328,326 shares during the last quarter. FMR LLC grew its position in Option Care Health by 134.0% during the 3rd quarter. FMR LLC now owns 7,516,448 shares of the company's stock worth $235,265,000 after acquiring an additional 4,304,896 shares during the last quarter. Westfield Capital Management Co. LP increased its holdings in Option Care Health by 10.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company's stock valued at $203,204,000 after purchasing an additional 599,589 shares in the last quarter. State Street Corp raised its position in Option Care Health by 1.4% in the 3rd quarter. State Street Corp now owns 6,257,172 shares of the company's stock valued at $195,849,000 after purchasing an additional 83,395 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA boosted its stake in Option Care Health by 2.6% in the third quarter. Massachusetts Financial Services Co. MA now owns 2,518,923 shares of the company's stock worth $78,842,000 after purchasing an additional 63,955 shares in the last quarter. 98.05% of the stock is owned by institutional investors.
Insider Activity at Option Care Health
In related news, insider Michael Bavaro sold 30,996 shares of the firm's stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. This trade represents a 40.80 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 0.64% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
A number of research analysts recently issued reports on the company. Bank of America raised Option Care Health from a "neutral" rating to a "buy" rating and lifted their price target for the company from $26.00 to $33.00 in a report on Monday, January 13th. Barrington Research upped their target price on shares of Option Care Health from $33.00 to $38.00 and gave the stock an "outperform" rating in a research report on Thursday, February 27th. JPMorgan Chase & Co. boosted their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. Jefferies Financial Group upgraded Option Care Health from a "hold" rating to a "buy" rating and increased their price objective for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. Finally, UBS Group initiated coverage on Option Care Health in a research note on Thursday, December 5th. They set a "neutral" rating and a $26.00 price target on the stock. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $33.00.
Check Out Our Latest Stock Analysis on Option Care Health
Option Care Health Trading Down 0.4 %
NASDAQ:OPCH traded down $0.15 during mid-day trading on Wednesday, hitting $35.03. The company had a trading volume of 1,069,591 shares, compared to its average volume of 1,641,080. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53. The firm has a market cap of $5.75 billion, a P/E ratio of 29.44, a P/E/G ratio of 2.30 and a beta of 1.33. The business's fifty day moving average is $32.11 and its two-hundred day moving average is $28.33.
Option Care Health Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Further Reading
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
